// App-Quantinova.ai

1215 : Utilization of podoplanin as a chemotherapeutic target for oral squamous cell carcinoma

Researchers

Presenter

  • Edward P. Retzbach

Principal Investigators

  • Harini Krishnan

  • Jhon A. Ochoa-Alvarez

  • Yongquan Shen

  • Evan Nevel

  • David J. Kephart

  • Evelyne Kalyoussef

  • Soly Baredes

  • Mahnaz Fatahzadeh

  • Maria I. Rameriz

  • Kingsley Yin

  • Mary Ann Young

  • Lisa Deluca-Rapone

  • Alan J. Shienbaum

  • Lasse D. Jensen

  • Gary S. Goldberg

Medical Centers

  • Rowan University School of Medicine, Stratford, NJ

  • Rutgers-New Jersey Medical School, Newark, NJ

  • Rutgers School of Dental Medicine, Newark, NJ

  • Boston Univ, Dept Med, Sch Med, Ctr Pulm, Boston, MA

  • Linkoping University, Linkoping, Sweden

Locations

  • United States

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Dental and Oral Health

Disease

  • Oral Squamous Cell Carcinoma

  • Oral cancer

  • Solid malignancies

Biomarkers

  • Cyclic AMP-dependent protein kinase

  • Cyclin dependent kinase 5

  • Galectin-3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved